{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:14:54Z","timestamp":1792080894231,"version":"4.4.0"},"reference-count":272,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bcp.2007.08.005","type":"journal-article","created":{"date-parts":[[2007,8,10]],"date-time":"2007-08-10T18:08:36Z","timestamp":1186769316000},"page":"34-56","source":"Crossref","is-referenced-by-count":206,"title":["Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings"],"prefix":"10.1016","volume":"75","author":[{"given":"Bankole A.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2007.08.005_bib1","unstructured":"U.S. Department of Health and Human Services. 10th Special report to the U.S. Congress on alcohol and health. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2000."},{"key":"10.1016\/j.bcp.2007.08.005_bib2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2007.08.005_bib3","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199905133401907","article-title":"Drug therapy for alcohol dependence","volume":"340","author":"Swift","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2007.08.005_bib4","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1360-0443.1996.tb03801.x","article-title":"The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects","volume":"91","author":"Finney","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2007.08.005_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.61.9.905","article-title":"Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals","volume":"61","author":"Johnson","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib6","series-title":"Handbook of clinical alcoholism treatment","first-page":"282","article-title":"Brief Behavioral Compliance Enhancement Treatment (BBCET) manual","author":"Johnson","year":"2003"},{"key":"10.1016\/j.bcp.2007.08.005_bib7","unstructured":"Pettinati HM, Weiss RD, Miller WR, Donovan D, Ernst DB, Rounsaville BJ. COMBINE monograph series, vol. 2. Medical Management Treatment Manual: a clinical research guide for medically trained clinicians providing pharmacotherapy as part of the treatment for alcohol dependence (DHHS Publication No. 04-5289). Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2004."},{"key":"10.1016\/j.bcp.2007.08.005_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/alcalc\/agh163","article-title":"Effects of naltrexone on the ethanol-induced changes in the rat central dopaminergic system","volume":"40","author":"Lee","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib9","series-title":"Drug addiction and its treatment: nexus of neuroscience and behavior","first-page":"137","article-title":"Neurobiological basis of drug reinforcement","author":"Hemby","year":"1997"},{"key":"10.1016\/j.bcp.2007.08.005_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-8993(83)90913-7","article-title":"Morphine-induced activation of A10 dopamine neurons in the rat","volume":"277","author":"Gysling","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2007.08.005_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0306-4522(84)90048-4","article-title":"Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine","volume":"11","author":"Matthews","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2007.08.005_bib13","first-page":"202","article-title":"Alcohol-seeking behavior. The roles of the hypothalamic\u2013pituitary\u2013adrenal axis and the endogenous opioid system","volume":"22","author":"Gianoulakis","year":"1998","journal-title":"Alcohol Health Res World"},{"key":"10.1016\/j.bcp.2007.08.005_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130000371","article-title":"Neuropharmacological treatments for alcoholism: scientific basis and clinical findings","volume":"149","author":"Johnson","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib15","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/sj.npp.1300994","article-title":"Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism","volume":"31","author":"Krystal","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.npp.1300306","article-title":"GABA(A) and opioid receptors of the central nucleus of the amygdala selectively regulate ethanol-maintained behaviors","volume":"29","author":"Foster","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib17","doi-asserted-by":"crossref","first-page":"PL241","DOI":"10.1016\/S0024-3205(99)00144-7","article-title":"Roles of 5-HT3 and opioid receptors in the ethanol-induced place preference in rats exposed to conditioned fear stress","volume":"64","author":"Matsuzawa","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2007.08.005_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/alcalc\/agh112","article-title":"Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects","volume":"40","author":"Manzanares","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2005.07.066","article-title":"Glycyl-glutamine in nucleus accumbens reduces ethanol intake in alcohol preferring (P) rats","volume":"1058","author":"Resch","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib20","first-page":"330","article-title":"Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors","volume":"45","author":"Raynor","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(24)39326-7","article-title":"Mu-opioid receptor knockout mice do not self-administer alcohol","volume":"293","author":"Roberts","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2007.08.005_bib22","doi-asserted-by":"crossref","first-page":"RC184:1","DOI":"10.1523\/JNEUROSCI.21-23-j0002.2001","article-title":"Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine","volume":"21","author":"Olive","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2007.08.005_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00213-003-1490-2","article-title":"A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration","volume":"169","author":"Marinelli","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.neuroscience.2004.05.047","article-title":"An in vivo profile of beta-endorphin release in the arcuate nucleus and nucleus accumbens following exposure to stress or alcohol","volume":"127","author":"Marinelli","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2007.08.005_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pbb.2006.07.028","article-title":"Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone","volume":"85","author":"Zalewska-Kaszubska","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0024-3205(80)90257-X","article-title":"Alteration of ethanol self-administration by naltrexone","volume":"26","author":"Altshuler","year":"1980","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2007.08.005_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0091-3057(85)90491-5","article-title":"Oral ethanol self-administration in the rat: effect of naloxone","volume":"22","author":"Samson","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF02244246","article-title":"Importance of delta opioid receptors in maintaining high alcohol drinking","volume":"103","author":"Froehlich","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000118113","article-title":"Naloxone reduces alcohol intake in a free-choice procedure even when both drinking bottles contain saccharin sodium or quinine substances","volume":"12","author":"De Witte","year":"1984","journal-title":"Neuropsychobiology"},{"issue":"suppl 1","key":"10.1016\/j.bcp.2007.08.005_bib30","first-page":"333","article-title":"Naloxone attenuation of voluntary alcohol consumption","author":"Froehlich","year":"1987","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0091-3057(90)90174-G","article-title":"Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference","volume":"35","author":"Froehlich","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib32","first-page":"165","article-title":"Neuropeptides and alcohol addiction in monkeys","volume":"71","author":"van Ree","year":"1994","journal-title":"EXS"},{"key":"10.1016\/j.bcp.2007.08.005_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0006-8993(93)90672-A","article-title":"The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57B1\/6 mice in a restricted access paradigm","volume":"630","author":"Le","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0024-3205(86)90601-6","article-title":"Naltrexone blocks the post-shock increase of ethanol consumption","volume":"38","author":"Volpicelli","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2007.08.005_bib35","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/sj.npp.1300175","article-title":"Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats","volume":"28","author":"Heyser","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-007-0711-5","article-title":"Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL\/6J mice","volume":"192","author":"Kamdar","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib37","first-page":"326","article-title":"Ethanol preference in the hamster: effects of morphine sulfate and naltrexone, a long-acting morphine antagonist","volume":"19","author":"Ross","year":"1976","journal-title":"Proc West Pharmacol Soc"},{"key":"10.1016\/j.bcp.2007.08.005_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0376-8716(84)90065-6","article-title":"Effects of naloxone on ethanol dependence in rats","volume":"13","author":"Berman","year":"1984","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2007.08.005_bib39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1530-0277.2006.00313.x","article-title":"Alcohol consumption is enhanced after naltrexone treatment","volume":"31","author":"Juarez","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.ALC.0000121655.48922.C4","article-title":"Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic\u2013pituitary\u2013adrenal activity in rhesus monkeys","volume":"28","author":"Williams","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050169","article-title":"Endogenous opioid systems and alcohol addiction","volume":"129","author":"Herz","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0741-8329(95)02035-7","article-title":"Implication of the endogenous opioid system in excessive ethanol consumption","volume":"13","author":"Gianoulakis","year":"1996","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0006-8993(99)01384-0","article-title":"Ethanol oral self-administration is increased in mutant mice with decreased beta-endorphin expression","volume":"835","author":"Grisel","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib44","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1176\/ajp.151.10.1463","article-title":"Naltrexone-induced alterations in human ethanol intoxication","volume":"151","author":"Swift","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1530-0277.1996.tb01679.x","article-title":"Naltrexone increases the latency to drink alcohol in social drinkers","volume":"20","author":"Davidson","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00008877-199506000-00009","article-title":"Effects of naltrexone pretreatment on the subjective and performance effects of ethanol in social drinkers","volume":"6","author":"Doty","year":"1995","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130050156","article-title":"Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence","volume":"129","author":"King","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib48","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.biopsych.2006.11.018","article-title":"Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking","volume":"62","author":"Krishnan-Sarin","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib49","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1530-0277.2006.00156.x","article-title":"Genetic moderators of naltrexone's effects on alcohol cue reactivity","volume":"30","author":"McGeary","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib50","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib51","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence: a controlled study","volume":"49","author":"O\u2019Malley","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib52","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib53","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1037\/0022-006X.64.5.1044","article-title":"Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching","volume":"64","author":"Jaffe","year":"1996","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.bcp.2007.08.005_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/ajp.153.2.281","article-title":"Experience of a \u201cslip\u201d among alcoholics treated with naltrexone or placebo","volume":"153","author":"O\u2019Malley","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib55","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1176\/ajp.152.4.613","article-title":"Effect of naltrexone on alcohol \u201chigh\u201d in alcoholics","volume":"152","author":"Volpicelli","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib56","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review","volume":"99","author":"Bouza","year":"2004","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.005_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001867.pub2","article-title":"Opioid antagonists for alcohol dependence","author":"Srisurapanont","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bcp.2007.08.005_bib58","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.1997.01830200071010","article-title":"Naltrexone and alcohol dependence: role of subject compliance","volume":"54","author":"Volpicelli","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib59","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1530-0277.1996.tb05264.x","article-title":"Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991","volume":"20","author":"Litten","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s002130050686","article-title":"Advances in development of medications for alcoholism treatment","volume":"139","author":"Litten","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib61","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archpsyc.1997.01830240090013","article-title":"The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study","volume":"54","author":"Croop","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib62","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence \u2013 The COMBINE Study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2007.08.005_bib63","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1530-0277.2007.00339.x","article-title":"Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study","volume":"31","author":"Gelernter","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib64","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2007.08.005_bib65","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1074\/jbc.M006352200","article-title":"A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling","volume":"276","author":"Befort","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2007.08.005_bib66","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1471-4159.2004.02340.x","article-title":"Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor","volume":"89","author":"Beyer","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2007.08.005_bib67","doi-asserted-by":"crossref","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2007.08.005_bib68","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.mp.4000556","article-title":"Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects","volume":"4","author":"Gelernter","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib69","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/hmg\/ddl024","article-title":"Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence","volume":"15","author":"Zhang","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bcp.2007.08.005_bib70","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0893-133X(01)00416-X","article-title":"Hypothalamic\u2013pituitary\u2013adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism","volume":"26","author":"King","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib71","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/105504901750532148","article-title":"Predicting treatment response to naltrexone: the influence of craving and family history","volume":"10","author":"Monterosso","year":"2001","journal-title":"Am J Addict"},{"key":"10.1016\/j.bcp.2007.08.005_bib72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bcp.2007.08.005_bib73","series-title":"Biodegradable polymers as drug delivery systems","first-page":"1","article-title":"Controlled release of bioactive agents from lactide\/glycolide polymers","author":"Lewis","year":"1990"},{"key":"10.1016\/j.bcp.2007.08.005_bib74","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/01.ALC.0000139823.30096.52","article-title":"A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex\u00ae) in patients with alcohol dependence","volume":"28","author":"Johnson","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib75","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2007.08.005_bib76","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.ALC.0000130804.08397.29","article-title":"Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial","volume":"28","author":"Kranzler","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib77","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-244X-5-18","article-title":"Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial","volume":"5","author":"Galloway","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib78","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1530-0277.2002.tb02542.x","article-title":"CDT, GGT, and AST as markers of alcohol use: the WHO\/ISBRA collaborative project","volume":"26","author":"Conigrave","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib79","first-page":"1074","article-title":"Sustained-release naltrexone for alcoholism treatment: a preliminary study","volume":"22","author":"Kranzler","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib80","unstructured":"Alim TN, Tai B, Chiang CN, Green T, Rosse RB, Lindquist T, et al. Tolerability study of a depot form of naltrexone substance abusers [abstract]. In: Harris LS, editor. Problems of drug dependence 1994: Proceedings of the 56th annual scientific meeting. vol. II. The College on Problems of Drug Dependence, Inc. NIDA Res Monogr 1995;153:253."},{"key":"10.1016\/j.bcp.2007.08.005_bib81","unstructured":"Heishman SJ, Francis-Wood A, Keenan RM, Chiang CN, Terrill JB, Tai B, et al. Safety and pharmacokinetics of a new formulation of naltrexone [abstract]. In: Harris LS, editor. Problems of drug dependence 1993: Proceedings of the 55th annual scientific meeting. vol. II. The College on Problems of Drug Dependence, Inc. NIDA Res Monogr 1994;141:82."},{"key":"10.1016\/j.bcp.2007.08.005_bib82","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002130100909","article-title":"Depot naltrexone: long-lasting antagonism of the effects of heroin in humans","volume":"159","author":"Comer","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib83","series-title":"Acamprosate in relapse prevention of alcoholism","first-page":"65","article-title":"Actions of acamprosate on neurons of the central nervous system","author":"Zieglgansberger","year":"1996"},{"key":"10.1016\/j.bcp.2007.08.005_bib84","series-title":"Drugs for relapse prevention of alcoholism","first-page":"73","article-title":"Acamprosate: preclinical data","author":"De Witte","year":"2005"},{"key":"10.1016\/j.bcp.2007.08.005_bib85","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/00023210-200519060-00004","article-title":"Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action","volume":"19","author":"De Witte","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2007.08.005_bib86","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/j.1530-0277.2002.tb02484.x","article-title":"Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors","volume":"26","author":"Harris","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib87","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0091-3057(84)80020-9","article-title":"A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved?","volume":"21","author":"Boismare","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0741-8329(87)90006-1","article-title":"Lack of effects of Ca-acetyl homotaurinate on chronic and acute toxicities of ethanol in rats","volume":"4","author":"Le Magnen","year":"1987","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib89","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1530-0277.2001.tb02220.x","article-title":"Effects of acamprosate on ethanol-seeking and self-administration in the rat","volume":"25","author":"Czachowski","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1369-1600.2006.00004.x","article-title":"Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone","volume":"11","author":"Escher","year":"2006","journal-title":"Addict Biol"},{"key":"10.1016\/j.bcp.2007.08.005_bib91","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0925-4927(98)00016-X","article-title":"Central effects of acamprosate. Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats","volume":"82","author":"Dahchour","year":"1998","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib92","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(95)00344-K","article-title":"Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum","volume":"283","author":"Rossetti","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib93","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/oxfordjournals.alcalc.a045093","article-title":"Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour","volume":"26","author":"Gewiss","year":"1991","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(96)00175-6","article-title":"Acamprosate and alcohol. II. Effects on alcohol withdrawal in the rat","volume":"305","author":"Spanagel","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib95","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0925-4927(98)00017-1","article-title":"Central effects of acamprosate. Part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers","volume":"82","author":"Bolo","year":"1998","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(96)00696-6","article-title":"The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal","volume":"317","author":"Putzke","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib97","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1360-0443.1995.tb01088.x","article-title":"Acamprosate in alcohol dependence: how does it work?","volume":"90","author":"Littleton","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2007.08.005_bib98","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1196\/annals.1300.010","article-title":"NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy","volume":"1003","author":"Krystal","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bcp.2007.08.005_bib99","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0741-8329(89)90059-1","article-title":"Long and short alcohol deprivation: effects on AA and P alcohol-preferring rats","volume":"6","author":"Sinclair","year":"1989","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib100","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2007.08.005_bib101","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(96)00174-4","article-title":"Acamprosate and alcohol. I. Effects on alcohol intake following alcohol deprivation in the rat","volume":"305","author":"Spanagel","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib102","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0166-4328(95)00131-C","article-title":"From controlled drug intake to loss of control: the irreversible development of drug addiction in the rat","volume":"70","author":"Wolffgramm","year":"1995","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib103","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0165-6147(97)89800-8","article-title":"Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes","volume":"18","author":"Spanagel","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2007.08.005_bib104","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0893-133X(02)00368-8","article-title":"A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone","volume":"27","author":"Mason","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.jcp.0000084029.22282.bb","article-title":"Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects","volume":"23","author":"Johnson","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib106","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.euroneuro.2007.02.012","article-title":"The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics","volume":"17","author":"Ooteman","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib107","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.ALC.0000108656.81563.05","article-title":"The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis","volume":"28","author":"Mann","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib108","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1530-0277.2001.tb02356.x","article-title":"Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis","volume":"25","author":"Kranzler","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib109","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0269881103174017","article-title":"Does acamprosate improve reduction of drinking as well as aiding abstinence?","volume":"17","author":"Chick","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpsychires.2006.02.002","article-title":"Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation","volume":"40","author":"Mason","year":"2006","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib111","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-004-1991-7","article-title":"Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients","volume":"178","author":"Verheul","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib112","first-page":"339","article-title":"Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism?","volume":"7","author":"Nagy","year":"2004","journal-title":"IDrugs"},{"key":"10.1016\/j.bcp.2007.08.005_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.fbp.0000181600.95405.c7","article-title":"N-Methyl-d-aspartate and group I metabotropic glutamate receptors are involved in the expression of ethanol-induced sensitization in mice","volume":"17","author":"Kotlinska","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib114","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00213-003-1617-5","article-title":"Acute effects of memantine in combination with alcohol in moderate drinkers","volume":"172","author":"Bisaga","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1176\/ajp.2007.164.3.519","article-title":"Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients","volume":"164","author":"Krupitsky","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib116","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1530-0277.2007.00360.x","article-title":"A pilot double-blind treatment trial of memantine for alcohol dependence","volume":"31","author":"Evans","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"suppl 1","key":"10.1016\/j.bcp.2007.08.005_bib117","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.2000.tb02164.x","article-title":"Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons","volume":"41","author":"Gibbs","year":"2000","journal-title":"Epilepsia"},{"issue":"suppl 1","key":"10.1016\/j.bcp.2007.08.005_bib118","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1111\/j.1528-1157.2000.tb02171.x","article-title":"Topiramate blocks kainate-evoked cobalt influx into cultured neurons","volume":"41","author":"Skradski","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2007.08.005_bib119","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1523\/JNEUROSCI.23-18-07069.2003","article-title":"Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons","volume":"23","author":"Gryder","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2007.08.005_bib120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0920-1211(97)00045-4","article-title":"Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold","volume":"28","author":"White","year":"1997","journal-title":"Epilepsy Res"},{"issue":"suppl 1","key":"10.1016\/j.bcp.2007.08.005_bib121","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/j.1528-1157.2000.tb02165.x","article-title":"Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism","volume":"41","author":"White","year":"2000","journal-title":"Epilepsia"},{"issue":"suppl 1","key":"10.1016\/j.bcp.2007.08.005_bib122","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1111\/j.1528-1157.2000.tb02173.x","article-title":"Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate","volume":"41","author":"Zhang","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2007.08.005_bib123","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(24)38047-4","article-title":"Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate","volume":"288","author":"Taverna","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2007.08.005_bib124","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00171-X","article-title":"Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance","volume":"42","author":"Herrero","year":"2002","journal-title":"Neuropharmacology"},{"issue":"suppl 1","key":"10.1016\/j.bcp.2007.08.005_bib125","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/j.1528-1157.2000.tb06047.x","article-title":"Topiramate as an inhibitor of carbonic anhydrase isoenzymes","volume":"41","author":"Dodgson","year":"2000","journal-title":"Epilepsia"},{"issue":"suppl 1","key":"10.1016\/j.bcp.2007.08.005_bib126","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2007.08.005_bib127","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/01.ALC.0000134533.96915.08","article-title":"Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study","volume":"28","author":"Johnson","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib128","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00023210-200519100-00005","article-title":"Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function","volume":"19","author":"Johnson","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2007.08.005_bib129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.ALC.0000150014.79657.64","article-title":"Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL\/6J mice","volume":"29","author":"Gabriel","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/syn.20350","article-title":"Topiramate reduces ethanol consumption by C57BL\/6 mice","volume":"61","author":"Nguyen","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.bcp.2007.08.005_bib131","unstructured":"Lynch WJ, Johnson BA. Effects of topiramate on alcohol consumption in the rat [abstract]. Alcohol Clin Exp Res 2007;31(s2):261A."},{"key":"10.1016\/j.bcp.2007.08.005_bib132","doi-asserted-by":"crossref","unstructured":"Farook JM, Morrell DJ, Lewis B, Littleton JM, Barron S. Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss-Webster mice. Alcohol Alcohol [in press].","DOI":"10.1093\/alcalc\/agm047"},{"key":"10.1016\/j.bcp.2007.08.005_bib133","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/01.alc.0000174690.63787.fc","article-title":"Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry","volume":"29","author":"Johnson","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib134","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2007.08.005_bib135","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1360-0443.2006.01576.x","article-title":"Topiramate reduces the harm of excessive drinking: implications for public health and primary care","volume":"101","author":"Ma","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2007.08.005_bib136","series-title":"Poster presentation at the 45th annual meeting of the American College of Neuropsychopharmacology","article-title":"Effects of topiramate on alcohol cue reactivity and the subjective effects of drinking","author":"Miranda","year":"2006"},{"key":"10.1016\/j.bcp.2007.08.005_bib137","series-title":"New Research poster presentation at the 160th annual meeting of the American Psychiatric Association","article-title":"Topiramate for the treatment of alcohol dependence: results of a multi-site trial","author":"Johnson","year":"2007"},{"key":"10.1016\/j.bcp.2007.08.005_bib138","series-title":"Investigator's Brochure: Topiramate (RWJ-17021-000)","author":"Johnson & Johnson Pharmaceutical Research & Development","year":"2005"},{"key":"10.1016\/j.bcp.2007.08.005_bib139","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1345\/aph.10093","article-title":"Topiramate titration and tolerability","volume":"35","author":"Biton","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bcp.2007.08.005_bib140","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1126\/science.160.3835.1469","article-title":"Alcohol preference in the rat: reduction following depletion of brain serotonin","volume":"160","author":"Myers","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.bcp.2007.08.005_bib141","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.168.3936.1244","article-title":"Alcohol aversion in the rat: behavioral assessment of noxious drug effects","volume":"168","author":"Nachman","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.bcp.2007.08.005_bib142","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0091-3057(85)90378-8","article-title":"Isolation and striatal (3H) serotonin uptake: role in the voluntary intake of ethanol by rats","volume":"22","author":"Daoust","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib143","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0091-3057(73)90130-5","article-title":"Effects of para-chlorophenylalanine and 5-hydroxytryptophan on alcohol intake in the rat","volume":"1","author":"Geller","year":"1973","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib144","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0741-8329(88)90019-5","article-title":"Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats","volume":"5","author":"Gill","year":"1988","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0741-8329(88)90020-1","article-title":"A further examination of the effects of sertraline on voluntary ethanol consumption","volume":"5","author":"Gill","year":"1988","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib146","series-title":"Research advances in new psychopharmacological treatments for alcoholism: proceedings of the symposium","first-page":"87","article-title":"Serotonin and ethanol aversion in the rat","author":"Zabik","year":"1985"},{"key":"10.1016\/j.bcp.2007.08.005_bib147","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4899-1678-5_10","article-title":"Serotonin and ethanol preference","volume":"7","author":"McBride","year":"1989","journal-title":"Recent Dev Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib148","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1530-0277.2006.00241.x","article-title":"Ethanol-related behaviors in serotonin transporter knockout mice","volume":"30","author":"Boyce-Rustay","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib149","series-title":"Drugs and appetite","first-page":"41","article-title":"Behavioural pharmacology of feeding","author":"Blundell","year":"1982"},{"key":"10.1016\/j.bcp.2007.08.005_bib150","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0028-3908(84)90098-4","article-title":"Serotonin and appetite","volume":"23","author":"Blundell","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib151","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0741-8329(98)00046-9","article-title":"Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats","volume":"17","author":"Maurel","year":"1999","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib152","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-4899-1678-5_12","article-title":"Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies","volume":"7","author":"Gill","year":"1989","journal-title":"Recent Dev Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib153","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0447.1981.tb00739.x","article-title":"Influence of depression and antidepressants on weight","volume":"290","author":"Gottfries","year":"1981","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.bcp.2007.08.005_bib154","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2125.1981.tb01112.x","article-title":"Effect of zimelidine, a new antidepressant, on appetite and body weight","volume":"11","author":"Simpson","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00518178","article-title":"Fluoxetine suppresses palatability-induced ingestion","volume":"91","author":"Leander","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib156","series-title":"The neurobiology of motivation and reward","author":"Stellar","year":"1985"},{"key":"10.1016\/j.bcp.2007.08.005_bib157","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.929195","article-title":"Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats","volume":"198","author":"Wurtman","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.bcp.2007.08.005_bib158","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0024-3205(79)90339-4","article-title":"Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats","volume":"24","author":"Wurtman","year":"1979","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2007.08.005_bib159","first-page":"542","article-title":"5-Hydroxytryptamine control of meal to meal composition chosen by rats","volume":"42","author":"Li","year":"1983","journal-title":"Fed Proc"},{"key":"10.1016\/j.bcp.2007.08.005_bib160","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0091-3057(97)00036-1","article-title":"Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats","volume":"58","author":"Heisler","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib161","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0091-3057(99)00021-0","article-title":"Reduction of fat and protein intakes but not carbohydrate intake following acute and chronic fluoxetine in female rats","volume":"63","author":"Heisler","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib162","series-title":"Drugs and appetite","article-title":"The physiology of the meal","author":"Smith","year":"1982"},{"key":"10.1016\/j.bcp.2007.08.005_bib163","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0165-1838(84)90032-8","article-title":"Role of sensory input in the control of food intake","volume":"10","author":"Fantino","year":"1984","journal-title":"J Auton Nerv Syst"},{"key":"10.1016\/j.bcp.2007.08.005_bib164","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0031-9384(85)90266-5","article-title":"Effects of pre-feeding on food-approach latency and food consumption speed in food deprived rats","volume":"35","author":"Wise","year":"1985","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0091-3057(90)90236-B","article-title":"Reduction in oral ethanol self-administration in the rat by the 5-HT uptake blocker fluoxetine","volume":"35","author":"Haraguchi","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib166","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0741-8329(94)00079-S","article-title":"Selective serotonin reuptake inhibitors: effects of chronic treatment on ethanol-reinforced behavior in mice","volume":"12","author":"Gulley","year":"1995","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib167","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0741-8329(88)90066-3","article-title":"Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats","volume":"5","author":"Murphy","year":"1988","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib168","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/clpt.1984.46","article-title":"Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers","volume":"35","author":"Naranjo","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2007.08.005_bib169","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/clpt.1987.27","article-title":"The serotonin uptake inhibitor citalopram attenuates ethanol intake","volume":"41","author":"Naranjo","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2007.08.005_bib170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4899-1678-5_13","article-title":"Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers","volume":"7","author":"Naranjo","year":"1989","journal-title":"Recent Dev Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib171","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/clpt.1990.62","article-title":"Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers","volume":"47","author":"Naranjo","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2007.08.005_bib172","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/clpt.1992.85","article-title":"Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers","volume":"51","author":"Naranjo","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2007.08.005_bib173","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1530-0277.1992.tb01373.x","article-title":"Effect of fluoxetine on alcohol consumption in male alcoholics","volume":"16","author":"Gorelick","year":"1992","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib174","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1360-0443.1995.tb01013.x","article-title":"Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems","volume":"90","author":"Naranjo","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2007.08.005_bib175","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1530-0277.1996.tb01686.x","article-title":"A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment","volume":"20","author":"Kabel","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib176","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/ajp.152.3.391","article-title":"Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics","volume":"152","author":"Kranzler","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib177","first-page":"1597","article-title":"Serotonergic agents and alcoholism treatment: rebirth of the subtype concept\u2014an hypothesis","volume":"24","author":"Johnson","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib178","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1126\/science.2882604","article-title":"Neurogenetic adaptive mechanisms in alcoholism","volume":"236","author":"Cloninger","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bcp.2007.08.005_bib179","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archpsyc.1989.01810030031004","article-title":"Age of alcoholism onset. I. Relationship to psychopathology","volume":"46","author":"Buydens-Branchey","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"2 suppl","key":"10.1016\/j.bcp.2007.08.005_bib180","first-page":"19S","article-title":"Biologic correlates of suicidal risk and aggressive behavioral traits","volume":"12","author":"Linnoila","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib181","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archpsyc.1989.01810070039006","article-title":"Family history of alcoholism in violent offenders and impulsive fire setters","volume":"46","author":"Linnoila","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib182","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1530-0277.1996.tb01696.x","article-title":"Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics","volume":"20","author":"Kranzler","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib183","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1530-0277.2000.tb04648.x","article-title":"Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype","volume":"24","author":"Pettinati","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib184","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.ALC.0000130974.50563.04","article-title":"Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy","volume":"28","author":"Dundon","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2003.11.012","article-title":"Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology","volume":"74","author":"Chick","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2007.08.005_bib186","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archpsyc.1997.01830200024004","article-title":"Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial","volume":"54","author":"Cornelius","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib187","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.jcp.0000194620.61868.35","article-title":"Sertraline treatment of co-occurring alcohol dependence and major depression","volume":"26","author":"Kranzler","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib188","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.1996.03530340025025","article-title":"A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression","volume":"275","author":"Mason","year":"1996","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2007.08.005_bib189","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archpsyc.1996.01830030054009","article-title":"Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial","volume":"53","author":"McGrath","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0741-8329(87)90060-7","article-title":"Buspirone attenuates volitional alcohol intake in the chronically drinking monkey","volume":"4","author":"Collins","year":"1987","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib191","first-page":"157","article-title":"Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference","volume":"28","author":"Meert","year":"1993","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib192","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/syn.890010511","article-title":"Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain","volume":"1","author":"Blier","year":"1987","journal-title":"Synapse"},{"issue":"suppl 1","key":"10.1016\/j.bcp.2007.08.005_bib193","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000284626","article-title":"Buspirone in the treatment of alcoholic patients","volume":"22","author":"Bruno","year":"1989","journal-title":"Psychopathology"},{"key":"10.1016\/j.bcp.2007.08.005_bib194","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1530-0277.1996.tb05263.x","article-title":"Efficacy of buspirone in alcohol dependence: a review","volume":"20","author":"Malec","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2007-1014461","article-title":"Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats","volume":"24","author":"Meert","year":"1991","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib196","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0091-3057(92)90392-S","article-title":"Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide","volume":"43","author":"Myers","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib197","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0741-8329(93)90039-Q","article-title":"Involvement of the serotonergic system in ethanol intake in the rat","volume":"10","author":"Svensson","year":"1993","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib198","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0893-133X(95)00081-N","article-title":"Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone","volume":"14","author":"Myers","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib199","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0091-3057(97)00330-4","article-title":"Action of the 5-HT2A antagonist amperozide on alcohol-induced poikilothermia in rats","volume":"59","author":"Myers","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib200","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0091-3057(97)00598-4","article-title":"Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats","volume":"60","author":"Biggs","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.005_bib201","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1530-0277.1997.tb04475.x","article-title":"Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT2A antagonists amperozide and FG 5974","volume":"21","author":"Overstreet","year":"1997","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s002130050589","article-title":"Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol","volume":"137","author":"Roberts","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib203","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0741-8329(96)00061-4","article-title":"Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats","volume":"13","author":"Lankford","year":"1996","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00442004","article-title":"Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition","volume":"98","author":"Ugedo","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib205","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s002130050126","article-title":"Ritanserin in the treatment of alcohol dependence\u2014a multi-center clinical trial","volume":"128","author":"Johnson","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib206","first-page":"230","article-title":"Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial","volume":"23","author":"Wiesbeck","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib207","first-page":"263","article-title":"Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons","volume":"40","author":"Lovinger","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib208","first-page":"732","article-title":"Pharmacologic characteristics of potentiation of 5-HT3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells","volume":"278","author":"Zhou","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2007.08.005_bib209","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0028-3908(94)90131-7","article-title":"Alcohols potentiate ion current mediated by recombinant 5-HT3RA receptors expressed in a mammalian cell line","volume":"33","author":"Lovinger","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib210","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1152\/jn.1991.66.4.1329","article-title":"Inhibition of 5-HT3 receptor-mediated ion current by divalent metal cations in NCB-20 neuroblastoma cells","volume":"66","author":"Lovinger","year":"1991","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.bcp.2007.08.005_bib211","first-page":"181","article-title":"Ethanol potentiates ion current mediated by 5-HT3 receptors on neuroblastoma cells and isolated neurons","volume":"1","author":"Lovinger","year":"1991","journal-title":"Alcohol Alcohol Suppl"},{"key":"10.1016\/j.bcp.2007.08.005_bib212","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0197-0186(99)00054-6","article-title":"5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic","volume":"35","author":"Lovinger","year":"1999","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bcp.2007.08.005_bib213","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib214","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ddr.430300308","article-title":"Alcohol-induced reinforcement: dopamine and 5-HT3 receptor interactions in animals and humans","volume":"30","author":"Johnson","year":"1993","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.1992.tb25966.x","article-title":"Neural mechanisms of drug reinforcement","volume":"654","author":"Koob","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bcp.2007.08.005_bib216","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol Rev"},{"key":"10.1016\/j.bcp.2007.08.005_bib217","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0028-3908(85)90149-2","article-title":"Laterality of dopamine function and neuroleptic action in the amygdala in the rat","volume":"24","author":"Bradbury","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib218","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1476-5381.1990.tb14685.x","article-title":"Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat","volume":"99","author":"Hagan","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib219","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.6171884","article-title":"Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions","volume":"215","author":"Eison","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bcp.2007.08.005_bib220","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1476-5381.1987.tb11394.x","article-title":"Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain","volume":"92","author":"Costall","year":"1987","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib221","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0741-8329(93)90034-L","article-title":"Specific decreases in ethanol- but not water-reinforced responding produced by the 5-HT3 antagonist ICS 205-930","volume":"10","author":"Hodge","year":"1993","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib222","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/oxfordjournals.alcalc.a045088","article-title":"MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats","volume":"26","author":"Fadda","year":"1991","journal-title":"Alcohol Alcohol"},{"issue":"suppl 5","key":"10.1016\/j.bcp.2007.08.005_bib223","first-page":"49A","article-title":"Intracranial self-administration of ethanol into the posterior VTA of Wistar rats is mediated by 5-HT3 receptors [abstract]","volume":"23","author":"Rodd-Henricks","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib224","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02247375","article-title":"Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers","volume":"112","author":"Johnson","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0741-8329(95)00023-K","article-title":"Evidence that the amygdala is involved in the inhibitory effects of 5-HT3 receptor antagonists on alcohol drinking in rats","volume":"12","author":"Dyr","year":"1995","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib226","first-page":"141","article-title":"Serotonin and alcohol drinking","volume":"119","author":"Sellers","year":"1992","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.bcp.2007.08.005_bib227","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1615\/CritRevNeurobiol.v12.i4.40","article-title":"Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents","volume":"12","author":"McBride","year":"1998","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.bcp.2007.08.005_bib228","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF02246222","article-title":"Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure","volume":"117","author":"Tomkins","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib229","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0741-8329(94)90023-X","article-title":"Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats","volume":"11","author":"Beardsley","year":"1994","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib230","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0006-3223(95)00432-7","article-title":"Ondansetron alters human alcohol intoxication","volume":"40","author":"Swift","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib231","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00008877-199408000-00007","article-title":"Effects of ondansetron pretreatment on acute responses to ethanol in social drinkers","volume":"5","author":"Doty","year":"1994","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib232","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1530-0277.1994.tb00054.x","article-title":"Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence","volume":"18","author":"Sellers","year":"1994","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib233","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.284.8.963","article-title":"Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial","volume":"284","author":"Johnson","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2007.08.005_bib234","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/01.ALC.0000075547.77464.76","article-title":"Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study","volume":"27","author":"Kranzler","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib235","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0741-8329(95)00062-3","article-title":"Apomorphine and 7-OH DPAT reduce ethanol intake of P and HAD rats","volume":"13","author":"Russell","year":"1996","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib236","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1530-0277.1994.tb00104.x","article-title":"The subchronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol-preferring rats: development of tolerance and cross-tolerance","volume":"18","author":"Mason","year":"1994","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib237","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF02244123","article-title":"Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide","volume":"101","author":"Weiss","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib238","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1530-0277.1991.tb05197.x","article-title":"Bromocriptine in the treatment of alcohol dependence","volume":"15","author":"Dongier","year":"1991","journal-title":"Alcohol Clin Exp Res"},{"issue":"suppl 1 Pt A","key":"10.1016\/j.bcp.2007.08.005_bib239","doi-asserted-by":"crossref","first-page":"74A","DOI":"10.1097\/00002826-199201001-00040","article-title":"Novel neuropharmacological treatments of alcohol dependence","volume":"15","author":"Naranjo","year":"1992","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib240","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1530-0277.1995.tb01532.x","article-title":"A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders","volume":"19","author":"Powell","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib241","first-page":"58","article-title":"Ability of baclofen in reducing alcohol intake and withdrawal severity. I. Preclinical evidence","volume":"24","author":"Colombo","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib242","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0376-8716(02)00333-2","article-title":"Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats","volume":"70","author":"Colombo","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2007.08.005_bib243","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2004.03.065","article-title":"Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55,212-2 in alcohol-preferring rats","volume":"492","author":"Colombo","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib244","first-page":"67","article-title":"Ability of baclofen in reducing alcohol craving and intake. II. Preliminary clinical evidence","volume":"24","author":"Addolorato","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib245","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/alcalc\/37.5.504","article-title":"Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study","volume":"37","author":"Addolorato","year":"2002","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib246","series-title":"Handbook of clinical alcoholism treatment","first-page":"119","article-title":"Medications for the treatment of alcoholism","author":"Ait-Daoud","year":"2003"},{"key":"10.1016\/j.bcp.2007.08.005_bib247","series-title":"Antabuse [package insert]","author":"Sidmak Laboratories, Inc.","year":"2001"},{"key":"10.1016\/j.bcp.2007.08.005_bib248","doi-asserted-by":"crossref","first-page":"849","DOI":"10.12968\/hosp.2000.61.12.1483","article-title":"Disulfiram revisited","volume":"61","author":"O'Shea","year":"2000","journal-title":"Hosp Med"},{"key":"10.1016\/j.bcp.2007.08.005_bib249","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2007.08.005_bib250","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","article-title":"Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial","volume":"61","author":"Carroll","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib251","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugalcdep.2006.08.016","article-title":"Disulfiram effects on responses to intravenous cocaine administration","volume":"87","author":"Baker","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2007.08.005_bib252","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jama.1986.03380110055026","article-title":"Disulfiram treatment of alcoholism. A Veterans Administration cooperative study","volume":"256","author":"Fuller","year":"1986","journal-title":"J Am Med Assoc"},{"issue":"suppl 20","key":"10.1016\/j.bcp.2007.08.005_bib253","first-page":"11","article-title":"Pharmacologic approaches to the management of alcoholism","volume":"62","author":"Anton","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib254","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2007.08.005_bib255","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1073\/pnas.0336351100","article-title":"Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice","volume":"100","author":"Wang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2007.08.005_bib256","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1523\/JNEUROSCI.4403-06.2007","article-title":"Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration","volume":"27","author":"Caille","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2007.08.005_bib257","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1471-4159.1999.0720522.x","article-title":"Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells","volume":"72","author":"Basavarajappa","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2007.08.005_bib258","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.alcohol.2006.08.001","article-title":"SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats","volume":"39","author":"Lallemand","year":"2006","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib259","first-page":"1109","article-title":"Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers","volume":"20","author":"Rodriguez de Fonseca","year":"1999","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.bcp.2007.08.005_bib260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/alcalc\/agh114","article-title":"Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats","volume":"40","author":"Gessa","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bcp.2007.08.005_bib261","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2004.07.069","article-title":"Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats","volume":"498","author":"Colombo","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib262","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00213-005-0199-9","article-title":"Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats","volume":"183","author":"Economidou","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib263","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1460-9568.2005.04056.x","article-title":"Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats","volume":"21","author":"Cippitelli","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bcp.2007.08.005_bib264","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuint.2003.08.009","article-title":"Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex\u2014involvement of Na(+)\/K(+)-ATPase","volume":"44","author":"Steffens","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bcp.2007.08.005_bib265","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00210-004-0921-x","article-title":"Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain","volume":"369","author":"Moranta","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib266","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(01)01228-6","article-title":"The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus","volume":"426","author":"Tzavara","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.005_bib267","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/archinte.166.15.1547","article-title":"New weapon to curb smoking: no more excuses to delay treatment","volume":"166","author":"Johnson","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bcp.2007.08.005_bib268","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002130050365","article-title":"Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat","volume":"133","author":"Hemby","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.005_bib269","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.ALC.0000056617.68874.18","article-title":"Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods","volume":"27","author":"Dahchour","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib270","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.005_bib271","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1530-0277.2000.tb02048.x","article-title":"Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence","volume":"24","author":"Johnson","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bcp.2007.08.005_bib272","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1530-0277.2001.tb02289.x","article-title":"Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker","volume":"25","author":"Ait-Daoud","year":"2001","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295207005424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295207005424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:44:23Z","timestamp":1737359063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295207005424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":272,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0006295207005424"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2007.08.005","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}